A new replicon suitable for cloning and gene expression was successfully introduced into Streptococcus pneumoniae. The non-integrative lactococcal vectors pIL253 (high-copy) and pIL252 (low-copy), which are based on the promiscuous theta-replicating plasmid pAMβ1, were established in pneumococcus. The stability and the small size of these plasmids, together with the presence of a helpful multi-cloning site make them a useful genetic tool for gene expression in this bacterium. The functionality of the system was tested by cloning and expressing the pneumococcal RNase R in pIL253. Full constitutive expression of the cloned gene was observed, clearly demonstrating that this plasmid can be used as an expression vector in S. pneumoniae. Moreover, gene expression can be regulated by the use of the lowor high-copy vector versions. The existence of other replicative plasmids based on this family, which are also probably functional in pneumococcus, further broadens the cloning possibilities. We also show that S. pneumoniae cells can accommodate simultaneously pIL252 or pIL253 together with pLS1plasmid, a pMV158 derivative, which replicates via rolling circle mechanism. This fact greatly increases the ability to manipulate this bacterium.
Introduction
The pathogenic Gram-positive bacterium S. pneumoniae is one of the leading causes of nosocomial infections. Although normally found as a harmless commensal of the human upper respiratory tract, it may cause invasive infections like pneumonia, meningitis or sepsis, when the immune system weakens. Normal disease development begins with colonization of the nasopharynx followed by progression to the lung or bloodstream. Collectively, these diseases result in millions of deaths worldwide each year, affecting especially young children and the elderly. Understanding the mechanisms of pathogenesis is essential to identify new potential targets that can be used to design innovative drugs effective to combat this microorganism. This has prompted increased efforts to study this bacterium at the molecular level, which often requires the use of refined genetic tools. Although S. pneumoniae is a naturally transformable bacterium only a few indigenous cryptic plasmids have been identified and most of the plasmid vectors used for its manipulation were isolated from heterologous hosts. A shuttle vector between S. pneumoniae and Escherichia coli based on an indigenous plasmid has also been constructed {Munoz, 1999 #12}. However, non-integrative plasmid vectors are still very scarce and most of the studies have been carried out on the broad host range, rolling circle replicating (RCR) plasmid pMV158 {Burdett, 1980 #13} and on its derivative, pLS1 {Stassi, 1981 #14}. A set of plasmids based on this promiscuous replicon that can be used as gfp-fusions vectors using Green Fluorescent Protein (GFP) as a reporter for gene expression have been constructed {Acebo, 2000 #17;Fernandez de Palencia, 2000 #15; Nieto, 2000 #16; Nieto, 2003 #18}. An improved vector for regulated gene expression based on the same system has recently been reported {Ruiz-Maso, 2012 #19}. pLS1 derivatives allowing expression of mCherry or citrine fusion proteins have also been designed {Henriques, 2011 #20} and a plasmid tool based on pLS1 is available to study promoter and terminator sequences in S. pneumoniae and Enterococcus faecalis {Ruiz-Cruz, 2010 #21}.
However, most of the pLS1 derivatives are large plasmids that are not easy to handle. Most of them lack a useful multi-cloning site and the respective sequence is often not available.
These observations prompted us to search for cloning vectors based in another replicon that could be suitable for the expression of genes in S. pneumoniae. pIL253 is a pAMβ1-based plasmid, a well characterized theta-replicating promiscuous replicon isolated from Enterococcus faecalis {Bruand, 1991 #22}. Plasmids belonging to the pIL253 family were initially constructed for molecular cloning in Lactococcus lactis and have been extensively used for gene cloning and expression in Gram-positive bacteria. This is mainly due to their small size (< 5 kb) and stability, the presence of a useful multi-cloning site (MCS), sequence availability and their demonstrated ability to stably maintain large DNA inserts in L. lactis {Simon, 1988 #7}. Furthermore they are available in low-(pIL252) or high-(pIL253) copy number versions {Simon, 1988 #7}, which allows a better control of gene expression.
In this work we have examined the capability of these plasmids to be used as vectors for cloning and gene expression in S. pneumoniae. We show that pIL253 autonomously replicates and is stably maintained in this bacterium. Cloning of RNase R into pIL253 yielded high levels of RNA and protein, readily demonstrating the utility of this plasmid family as a pneumococcal expression vector. In addition the compatibility of pIL252 or pIL253 with pLS1, demonstrated in this work, is undoubtedly one the most useful properties of these plasmids.
Material and methods

Bacterial strains and growth conditions
All strains used in this work are listed in Table 1 . S. pneumoniae TIGR4 {Tettelin, 2001 #1} and derivatives were routinely grown in Todd Hewitt medium, supplemented with 0.5 % yeast extract (THY), at 37°C without shaking or in Trypticasein soy broth (TSB) agar plates supplemented with 5% sheep blood. When required the growth medium was supplemented with 2.5 or 3 µg/ml chloramphenicol (Cm), 5 μg/ml erythromycin (Ery) or 1 µg/ml tetracycline (Tet) as specified bellow. E. coli was cultivated in Lysogeny broth (LB) at 37 ºC with agitation.
The growth medium was supplemented with 100 μg/ml ampicillin (Amp) when required.
All oligonucleotides used in this work were synthesized by STAB Vida, Portugal.
DNA manipulations and plasmids
The lactococcal plasmid vectors pIL252 and pIL253 {Simon, 1988 #7} were transformed into S. pneumoniae TIGR4. Pneumococcal transformation was performed essentially as described {Burghout, 2007 #2}. Briefly pre-competent pneumococcal cells were grown for 10 min at 37°C in a 10-fold volume of CTM-pH 7.8 {Burghout, 2007 #2} supplemented with 125 ng/ml CSP-2 (the synthetic competence-stimulating peptide 2). Media were supplemented with Tet, when cells previously carried pLS1. 200 ng of plasmid DNA were then added and cultures were further incubated at 30 ºC for 30 min and then shifted to 37 ºC. One hour and thirty minutes after the temperature shift, transformants were selected on solid medium supplemented with 1 µg/ml Ery.
Isolation of plasmid DNA from S. pneumoniae was performed using the Wizard Plus SV Minipreps DNA purification system (Promega) with some modifications. Exponentially growing cells were harvested and resuspended in TES (25 mM Tris pH 8, 10 mM EDTA, 1.7 % saccharose) supplemented with 8 mg/ml lysozyme and incubated at 37 ºC for 15 min. The suspension was centrifuged at 2350 x g for 5 min, and the cell pellet was resuspended in 0.9 M NaCl (200 µl) and centrifuged again under the same conditions. The pellet was then processed following the supplier's instructions. Plasmid DNA was digested with PstI (Fermentas), as recommended by the supplier. pIL253 carrying the coding sequence of the TIGR4 RNase R inserted into the SmaI/PstI sites of the plasmid MCS {Moreira, in press #29} was used to assess the ability of pIL253 to stably carry and express a DNA fragment in S. pneumoniae. Expression of RNase R was evaluated by transforming this construction into a S. pneumoniae TIGR4 RNase R -mutant strain (see below). Transformants were selected with 1 µg/ml Ery and were further propagated in media containing Cm (3 µg/ml) and Ery (1 μg/ml).
The S. pneumoniae RNase R deficient mutant was created through allelic replacement mutagenesis, using a DNA fragment containing the rnr flanking regions, in which rnr is replaced by a chloramphenicol resistance cassette (cat). The cat marker was amplified with primers smd013 (GATAAGCTTGATGAAAATTTG) and smd014
(CATTATCTCATATTATAAAAG). The upstream and downstream rnr flanking regions were amplified by PCR using the primer pairs smd011 (5'-
CAAATTTTCATCAAGCTTATCATTTTCTTTCTAGATTTTTTAATTTTC-3') and smd016 (5'-
CGCGGATCCAATGAACAGGATTGGTATTG-3'), respectively. Primers smd015 and smd016 included 3' extensions complementary to the 5'-and 3'-end respectively of the cat marker.
The PCR amplified fragments with the complementary extensions were used as templates together with the cat marker to obtain a final PCR product. This product, which contained the rnr flanking regions surrounding the cat cassette, was inserted into the sites EcoRI/BamHI of pUC19 (Invitrogen) and propagated in E. coli DH5α. The recombinant plasmid was purified as described by Birnboim and Doly {Birnboim, 1979 #27}, linearized with EcoRI and used to transform S. pneumoniae 708 strain {Lacks, 1970 #28}. Competence and transformation procedures were performed according to {Lacks, 1968 #26}. Transformants were selected with Cm (2.5 g/ml), and the correct nucleotide sequence of the rnr::cat chromosomal insert was confirmed by DNA sequencing. Then, chromosomal DNA from S. pneumoniae 708 (rnr::cat) mutant (1 µg/ml) and the synthetic CSP-2 (25 ng/ml) were used to transform the S.
pneumoniae TIGR4 strain as above. Transformants containing the rnr::cat in their chromosome were selected for Cm (2.5 g/ml) and the correct nucleotide sequence was confirmed by DNA sequencing.
Plasmid segregational stability
Segregational stability was tested according to Simon and Chopin {Simon, 1988 #7}. Briefly, an overnight culture of S. pneumoniae TIGR4 containing pIL253 grown in medium supplemented with Ery was diluted to an OD 600 of 0.05 in fresh THY without antibiotic. The culture was allowed to grow until early stationary phase and then plated onto non-selective TSB agar. The fraction of erythromycin-resistant clones was determined by transferring ~150
of those colonies onto erythromycin-free and erythromycin-containing TSB agar plates.
Determination of copy number
Pneumococcal cultures of TIGR4 carrying pLS1, pIL252 or pIL253, were grown to an OD 650 = 0.45. Total DNA was prepared and fractionated in 1% agarose as described by Acebo et al. {Acebo, 1996 #30} . Gels were stained with ethidium bromide (0.5 µg mL Where Dp 1 and Dp 2 are, respectively, the intensity values determined for the open and covalently closed plasmid forms. M c is the molecular weight of the S. pneumoniae TIGR4 chromosome (2160837 bp) and D c is the intensity value for the chromosomal DNA. is the molecular weight of the plasmids: pLS1 (4408 bp), pIL252 (4698 bp) and pIL253 (4963 nt).
The coefficient 1.36 is introduced to correct the differences in fluorescence due to the efficiency of ethidium bromide for intercalation in open circle and supercoiled DNA.
RNA Extraction
Overnight cultures of S. pneumoniae TIGR4 wild type and derivatives were diluted in prewarmed THY to a final OD 600 of 0.1, and incubated at 37 ºC until OD 600 ~ 0.3. At this point, cultures were split into two aliquots and each was further incubated at 15 ºC or 37 ºC for 2 h. 20 ml culture samples were collected, mixed with 1 volume of stop solution (10 mM Tris pH 7.2, 25 mM NaNO 3 , 5 mM MgCl 2 , 500 µg/ml chloramphenicol) and harvested by centrifugation (10 min, 2800 x g, 4 ºC). Total RNA was extracted using Trizol reagent (Ambion) essentially as described by the manufacturer, with some modifications.
Pneumococcal cells were lysed by incubation in 650 µl lysis buffer (sodium citrate 150 mM, saccharose 25 %, sodium deoxicholate 0.1 %, SDS 0.01 %) for 15 min at 37 ºC followed by addition of 0.1 % SDS. After lysis, samples were treated with 10 U Turbo DNase (Ambion) for 1 h at 37 ºC. After extraction, the RNA integrity was evaluated by gel electrophoresis and its concentration estimated using a Nanodrop 1000 machine (Nanodrop Technologies).
Reverse Transcription-PCR (RT-PCR)
RT-PCR reactions were carried out using total RNA, with the OneStep RT-PCR kit (Qiagen), according to the supplier's instructions. The primer pair seqT4-2 (GACATCGCTATAGGTCATACG) / seqT4-3(GTTTGACAACAGTTGTCGGG) was used to analyze rnr expression. As an independent control, 16S rRNA was amplified with specific primers 16sF (AGAGTTTGATCCTGGCTCAG) and 16sR (ACGGCTACCTTGTTACGACTT).
Prior to RT-PCR, all RNA samples were treated with Turbo DNA free Kit (Ambion). Control experiments, run in the absence of reverse transcriptase, yielded no product.
Total Protein Extraction and Western Blotting
Cell cultures used to prepare protein extracts were grown in the same conditions as described above for RNA extraction. 20 ml culture samples were collected, mixed with 1 volume of stop solution (defined above) and harvested by centrifugation (10 min, 2800 xg, 4 ºC). The cell pellet was resuspended in 100 µl of TE buffer supplemented with 1 mM PMSF, 0.15 % sodium deoxycholate and 0.01 % SDS. After 15 min incubation at 37 ºC, SDS was added to a final concentration of 1 %. Protein concentration was determined using a Nanodrop 1000 machine (NanoDrop Technologies). 20 µg of total protein were separated in a 7 % tricine-SDS-polyacrylamide gel, following the modifications described by {Haider, 2010 #3}. After electrophoresis, proteins were transferred to a nitrocellulose membrane (Hybond ECL, GE Healthcare) by electroblotting using the Trans-Blot SD semidry electrophoretic system (BioRad). The membrane was then probed with 1:500 dilution of anti-RNase R antibodies {Moreira, in press #29}. ECL anti-rabbit IgG peroxidase conjugated (Sigma) was used as the secondary antibody in a 1:10000 dilution. Immunodetection was conducted via a chemiluminescence reaction using Western Lightning Plus-ECL Reagents (PerkinElmer).
Results and discussion
pIL253 autonomously replicates in S. pneumoniae
The scarcity of non-integrative plasmid-vectors available to genetically manipulate S.
pneumoniae (and which are mainly based on the replicon pMV158), associated with difficulties in handling the existent tools, prompted us to examine the ability of the lactococcal plasmid-vector pIL253 to autonomously replicate in S. pneumoniae.
For this purpose, pIL253 was transformed into S. pneumoniae TIGR4 and Ery resistant clones were analyzed for the presence of the plasmid. As shown in Fig. 1 pIL253 was isolated from exponentially growing transformants propagated in selective medium, indicating that this plasmid is able to autonomously replicate in pneumococcus. However, although pIL253 is stable in S. pneumoniae in the presence of selective pressure, only 5 % of the cells still carried the plasmid after continuous growth in the absence of Ery. The plasmid extracted from these cells showed the same electrophoretic mobility forms as observed in the original L.
lactis preparation. One fragment corresponding to the size of pIL253 (~5 kb) was observed after linearization of both plasmid preparations with the single cutter PstI (Fig. 1, lanes 3-4) .
Thus the plasmid isolated from S. pneumonia seems to be identical to the original L. lactis plasmid. The overall results indicate that pIL253 is structurally stable in S. pneumoniae and it can be stably maintained under selective pressure
Since the use of low-copy number vectors is often an advantage, we also tested pIL252, which is a low-copy number version of pIL253. The rep promoter activity is repressed by the product of the repF gene, which is present in pIL252 but is disrupted in pIL253, leading to the respective low and high copy numbers of these vectors {Simon, 1988 #7}. Analogously to pIL253, pIL252 can only be stably maintained in S. pneumoniae under selective pressure: in the absence of the antibiotic only 5 % of the cells retain the plasmid.
Together, the results presented here show that this vector family can be propagated in pneumococcal cells under antibiotic selective pressure.
pIL252/pIL253 compatibility with pLS1
An important property of a cloning vector is its compatibility with other vectors. Because they use different replication mechanisms, RCR-and theta-replicating vectors are often compatible. Thus we tested if pIL253 could be maintained in S. pneumoniae together with pLS1.
To this purpose S. pneumoniae TIGR4 cells carrying pLS1 were transformed with pIL252 or pIL253 and transformants, selected in media containing Tet and Ery, were tested for the presence of both plasmids. Plasmids extracted from exponentially growing single transformants were then compared with those extracted from double transformants by restriction analysis. The enzyme chosen (PstI) is a single cutter for pIL252/pIL253 and a double cutter for pLS1, giving rise to different sized fragments that can be easily identified.
The result obtained with pIL252 is shown in Fig. 2 . An analogous result was obtained when pIL253 was used instead (data not shown). The restriction analysis of plasmid DNA indicates that none of the plasmids underwent structural rearrangements. Thereby this result shows that pneumococcal cells are able to stably maintain both pIL252/pIL253 vectors and pLS1.
This feature represents a major advantage for their genetic manipulation.
Determination of pIL252 and pIL253 copy number
Analysis of total DNA preparations (Fig. 3) revealed that pIL253 as well as pLS1 are mainly present in monomeric supercoiled forms, whereas in some instances pIL252 multimers where observed in S. pneumoniae TIGR4.
Determination of plasmid copy number revealed the expected value of 20 + 2 for pLS1 as previously described {Lacks, 1986 #32;Acebo, 1996 #30}. The pIL252 plasmid presented a copy number of 27 + 2, whereas pIL253 showed 59 + 5. In addition, supporting the compatibility of pLS1 and the pIL plasmids, no significant influence in the copy number was observed by carrying pLS1/pIL252 or pLS1/pIL253 plasmids. However, unexpectively, it seems that in the presence of pLS1, pIL252 decreases the degree of multimerization.
Gene cloning and expression from pIL253
To assess the functionality of this plasmid as an expression vector in pneumococcus, the coding sequence of S. pneumoniae TIGR4 RNase R was inserted into the pIL253 multicloning site and this construction was transferred into an RNase R deficient strain. RNase R expression from pIL253 was then evaluated by RT-PCR and Western blotting. Since RNase R is known to be a protein that exhibits the highest expression levels under cold shock {Cairrão, 2003 #4;Moreira, in press #29}, the experiments were conducted at 15 ºC and 37 ºC, to have a better comparison with RNase R expression from the chromosome. The results in Fig. 4 show that RNase R is highly expressed from pIL253. Both mRNA and protein levels are higher than those detected with the wild type strain even at 15 ºC. We also observe that expression from this plasmid seems to be constitutive and does not change with temperature.
This plasmid has been extensively used for expression of homologous and heterologous genes in lactic acid bacteria and high expression levels have previously been reported (see for instance {de Vos, 1990 #8;van Alen-Boerrigter, 1991 #6; Kleerebezem, 1997 #9; Domingues, 2004 #10} . The high expression level may be a consequence of the gene dosage effect, since the copy number of pIL253 was calculated to be about 57 copies / chromosome. Moreover, this vector is known to contain a promoter in the replication region that reads through into the multiple cloning site {de Vos, 1990 #8} and it is probably implicated in the expression of genes cloned in the same transcriptional orientation. We believe that this work, by introducing the use of novel plasmid-based refined genetic tools, opens new perspectives for the study and genetic manipulation of the important human pathogen S. pneumoniae. M-Molecular weight marker; 1-pIL252; 2-pLS1; 3-pIL252 + pLS1. were separated in a 7 % tricine-SDS-polyacrylamide gel and blotted to a nitrocellulose membrane. RNase R was detected using specific antibodies. An RNase R -mutant strain was used as a negative control. A non-specific band (Control) detected with the same antibodies was used as loading control. 
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